The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
If the results are great then I’m not worried about future raises. We either won’t need one because a third party steps in and takes over, or we raise to capitalise on a proven resource and multiply company value. Both, even allowing for dilution in the latter, would benefit shareholders.
New here and still reading up, but I found this useful so other newbies might too.
https://www.helium-one.com/wp-content/uploads/2023/02/21-08-11-Hannam.pdf
It’s all interesting but iro 5085’s posts, I thought this bit especially so;
“There needs to be a thermal release of the helium produced in ancient deep crust and in Rukwa this is caused by the by the crust ripping apart due to a mantle plume…..This is exceedingly rare, which is why it is unusual to find large primary helium deposits globally.”
So the raise in temperature looks one great indicator to me, along with all the others.
Not without risk, but I’m in for what could well be a globally significant helium find.
I don’t think the increase in debt is surprising given interest is rolling up. This was the bit I didn’t like though…
“Current production, having improved from low historical levels, is still not at the level we would like.”
Doesn’t suggest to me that the Q4 results will be great.
Nope. “PGM” is not a company - it stands for Platinum Group Metals. We have not signed a deal “with” PGM, but with a Swiss company who has PGM and who wants Vast to represent it by marketing and distributing it for them.
PGM is mined in Zim, but the relevant RNS confirmed the PGM we are marketing and distributing for the Swiss company was produced in the EU.
Can anything be read into the timings of news and the timings of when placing shares hit the market?
Ie
2 x Good news releases, then...
Raise off the back of that news, but with only some of the shares hitting the market in Jan, then...
We can expect interims and possibly BP and other news all tomorrow, then...
The rest of the placing shares hit the market...
Now I’m confused ASI!
You replied to mine saying the diamond royalty rate was 20% (half payable in cash), but to Zac saying the royalty rate is 10%?
This would seem to me to confirm it’s 10% total rate, half paid in cash?
https://www.miningweekly.com/article/zimbabwes-new-mineral-royalty-policy-comes-into-force-2022-11-08
Two things for me stood out iro the diamonds
1. It’s been made clear that part of the raise is to be allocated to costs associated with their recovery.
2. AP said in the interview that he had expected the matter to be closed out before Christmas.
Both of these suggest to me that AP believes the recovery to be close. Whether or not that belief is justified or whether it’s naive remains to be seen.
Of course, AP could just be fibbing, but I don’t think so. Maybe that’s just me being naive.
My bet is that the diamonds are closer than ever before. Unfortunately, I also think that when they come their value will be much lower than some hope for.
Not showing on here so
https://www.londonstockexchange.com/news-article/VAST/holding-s-in-company/16306798
Whilst still having a healthy degree of scepticism borne out of past experience, AP did strike me as having more confidence re the diamonds in this interview and it seemed noteworthy to me that he explained both in the interview, and the RNS, that part of the placing will be needed for costs associated with the parcel.
I used to think like you Oofy but not so much now. It just makes zero sense, at least to me, why any third party would appoint Vast to act, on an exclusive basis, as an integral part of what could be a series of transactions with significant value, unless they were confident in our ability to deliver over at least the short to medium term.
And here we are, having been so appointed twice in the last week.
Nope. I simply posted a piece of factual information for awareness. Personally I don’t see any particular relevance to Vast and certainly don’t place anywhere like the degree of importance on this conference as others.
For info, the Zim Mining Investment Conference that was due to take place on 25/1 has been postponed.
https://www.eventbrite.com/e/postponed-tbc-zimbabwe-mining-investment-conference-london-2024-tickets-770294480527?aff=erelexpmlt
This article from November 2021 says
“The company has concluded a 510(K) initial Q-submission process with the US Food and Drug Administration (FDA) and is in the advanced stages to receive the CE Mark from the European Union (EU) for the test.”
https://www.medicaldevice-network.com/news/salignostics-saliva-test-kit-pregnancy/?cf-view
ABDX put this blog out today about the FDA Q submission process.
https://www.abingdonhealth.com/lateral-flow-development-fda-qsubmission-processed-explained/
It’s interesting in itself, but the most interesting thing is that the only ABDX customer I know of that followed this process is Salignostics, and they’ve been in that process if I recall since late 2021 (could be wrong).
Perhaps Salistick FDA approval might be close…?